| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
| 09/02/2008 | US7419794 Antibodies specific for CYP1B1 |
| 09/02/2008 | US7419793 Flea octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 09/02/2008 | US7419792 Detecting binding of said antigen in tissue sample; treating cells to aid in differentiation, treatment and diagnostic imaging |
| 09/02/2008 | US7419790 Sodium-independent transporter carrying acidic amino acid and its gene |
| 09/02/2008 | US7419789 Method of inhibiting binding of Dengue virus to a human cell with DC-SIGN blockers |
| 09/02/2008 | US7419672 Genes and proteins, and their use |
| 09/02/2008 | US7419671 For therapy and prophylaxis of Porphyromonas gingivalis infection |
| 09/02/2008 | US7419667 Drug for cancer therapy |
| 09/02/2008 | US7419666 Treatment of ocular disorders |
| 09/02/2008 | US7419665 Monoclonal antibodies for detection of urinary trypsin inhibitors |
| 09/02/2008 | US7419664 Expression or activity of soluble CLCA1(chloride channel A1) is up-regulated, by administering inhibitors of soluble CLCA1 |
| 09/02/2008 | US7419663 by administering a STIgMA polypeptide or its agonist; autoimmune, respiratory, kidney, skin, cardiovascular disorders, hepatitis |
| 09/02/2008 | US7419662 Methods of making chemokine alpha 3 antibodies |
| 09/02/2008 | US7419660 Isolating nucleic acid from malignant cells, inserting into expression vector, transformation; light regions differ by one idiotope |
| 09/02/2008 | US7419659 Nucleic acid comprising dicistronic message for producing antibody where cistron contains DNA coding heavy and light chains |
| 09/02/2008 | US7419658 Isolated ligand of ChemerinR |
| 09/02/2008 | US7419657 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines |
| 09/02/2008 | CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 09/02/2008 | CA2303478C Group a streptococcal vaccines |
| 09/02/2008 | CA2246430C Protein tyrosine phosphatases of hematopoietic cells |
| 09/02/2008 | CA2175577C Receptor on the surface of activated t-cells: acts-4 |
| 09/02/2008 | CA2144307C Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| 08/28/2008 | WO2008103905A2 Antibodies that specifically bind irta and methods of use |
| 08/28/2008 | WO2008103849A2 Methods and compounds for lymphoma cell detection and isolation |
| 08/28/2008 | WO2008103845A2 Monoclonal antibodies that neutralize anthrax toxins |
| 08/28/2008 | WO2008103812A1 Compositions and methods for diagnosing and treating endometriosis |
| 08/28/2008 | WO2008103473A1 Engineered anti-il-23p19 antibodies |
| 08/28/2008 | WO2008103472A2 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 08/28/2008 | WO2008103432A1 Engineered anti-il-23p19 antibodies |
| 08/28/2008 | WO2008103319A2 Compounds and methods for use in detecting gabapentin |
| 08/28/2008 | WO2008102495A1 Method for evaluating compound acting on mark4 |
| 08/28/2008 | WO2008102359A1 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 08/28/2008 | WO2008102123A1 Monoclonal anti-cxcl13 antibodies |
| 08/28/2008 | WO2008101985A2 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization |
| 08/28/2008 | WO2008101332A1 Triticum mosaic virus |
| 08/28/2008 | WO2008081031A3 Methods of increasing the production yield of a secreted antibody in a filamentous fungus by overexpression of the chaperone bip |
| 08/28/2008 | WO2008080218A9 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 08/28/2008 | WO2008057240A9 Crystalline anti-htnfalpha antibodies |
| 08/28/2008 | WO2008049209B1 Endophyte enhanced seedlings with increased pest tolerance |
| 08/28/2008 | WO2008013552A3 Fully human hybridoma fusion partner cell lines |
| 08/28/2008 | WO2008010980A3 Tat-049 and methods of assessing and treating cancer |
| 08/28/2008 | WO2007127506A8 Anti-ephrinb2 antibodies and methods using same |
| 08/28/2008 | WO2007090675A3 Novel oxidoreductases and uses thereof |
| 08/28/2008 | WO2007084253A3 High affinity antibodies against hmgb1 and methods of use thereof |
| 08/28/2008 | WO2007084181A3 Bispecific single chain fv antibody molecules and methods of use thereof |
| 08/28/2008 | WO2007076391A9 Tgf-beta binding compositions |
| 08/28/2008 | WO2006113782A3 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| 08/28/2008 | US20080207509 Scaffold |
| 08/28/2008 | US20080207506 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents |
| 08/28/2008 | US20080207459 Antibody diversity generation |
| 08/28/2008 | US20080207449 Polypeptides; antisense nucleic acids; gene expression vectors that have been inserted: transgenic plants; agriculture; diagnosis; screening; therapy |
| 08/28/2008 | US20080206867 Fc variants with optimized Fc receptor binding properties |
| 08/28/2008 | US20080206800 Method for Measuring Tyrosine Kinase Phosphorylation |
| 08/28/2008 | US20080206788 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
| 08/28/2008 | US20080206780 plurality of antibody fragments, each comprising a framework region having a murine VH14 heavy chain and a murine VK2 light chain, or homologues thereof, each antibody fragment further comprising at least one different CDR; immobilised on a support material |
| 08/28/2008 | US20080206318 Administering complex formed from a soluble tumor-associated antigen and an antibody or antigen binding fragment thereof that binds to a first epitope of the tumor-associated antigen, wherein the tumor-associated antigen is CA 125 for therapy of oncological disease |
| 08/28/2008 | US20080206283 Vaccine Against Sars |
| 08/28/2008 | US20080206269 stimulate the resuscitation of bacteria after true dormancy; cognate receptors, convertases, respective genes and inhibitors or mimetics |
| 08/28/2008 | US20080206268 HA-1 epitopes and uses thereof |
| 08/28/2008 | US20080206264 when bound by a highly potent human neutralizing monoclonal antibody specific for a V3 conformational epitope; immunogens for inducing broadly-neutralizing antibodies against HIV-1 as well as antagonists for inhibiting the binding of HIV-1 to the relevant co-receptors |
| 08/28/2008 | US20080206262 complexing of multiple antigens or proteins in a controlled, multivariable fashion, to one single primary recombinant monoclonal antibody; activate dendritic cells and other cells; bound to one half of a Coherin/Dockerin pair |
| 08/28/2008 | US20080206259 Unique and specific combinations of polyclonal anti-TNF and anti-IL-6 antibodies directed to cytokines; high-risk patients, including immunocompromised patients such as surgical and other hospitalized patients, low birth weight infants, and burn and trauma victims |
| 08/28/2008 | US20080206257 Reducing epithelial toxicity during cancer therapy by administering KGF with e.g. erlotinib, Iressa(TM), canertinib, or a monoclonal antibody against EGFR; side effect reduction of diarrhea, rash |
| 08/28/2008 | US20080206256 Treatments for cancer |
| 08/28/2008 | US20080206255 Antibody cancer immunotherapy |
| 08/28/2008 | US20080206254 human monoclonal antibody of the IgG isotype; preventing and treating cardiovascular disorders; specifically binds to the A2 domain of FVIII |
| 08/28/2008 | US20080206252 Novel Polypeptides, and Nucleic Acids Encoding the Same |
| 08/28/2008 | US20080206251 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases |
| 08/28/2008 | US20080206250 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206249 comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides |
| 08/28/2008 | US20080206248 associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, and for the prediction of the efficacy of anti-ErbB2 therapy in cancer patients; insertion mutations as well as point mutations |
| 08/28/2008 | US20080206247 Glycoprotein VI fusion proteins |
| 08/28/2008 | US20080206246 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 08/28/2008 | US20080206245 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206244 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206239 modified to remove one or more T-cell epitopes; modified anti HER2, anti Lewis Y antigen, anti IgE or anti TNF antibody; mouse antibody with reduced immunogenicity |
| 08/28/2008 | US20080206234 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206230 Peptides Derived from Human Bplp Protein, Polynucleotides Coding for Said Peptides and Antibodies Directed Against Said Peptides |
| 08/28/2008 | US20080206229 Modified Antibodies Recognizing Receptor Trimers or Higher Multimers |
| 08/28/2008 | US20080206220 Using NADH:flavin oxidoreductase as screening tool in identifying modulators for use in treatment of fungal infection |
| 08/28/2008 | US20080206219 Using cytokine modulators as therapeutic tools in treatment of vascular permeability disorders |
| 08/28/2008 | US20080206190 Glycosylated IL-7, Preparation And Uses |
| 08/28/2008 | US20080206140 Antibodies specific to malignant cancer specific proliferating cell nuclear antigen (csPCNA) and not to the non-malignant proliferating cell nuclear antigen (nmPCNA) isoform; cancer diagnosis, prognosis, tumor detection and therapy; immunoassay kit |
| 08/28/2008 | US20080206136 Binding Peptidomimetics and Uses of the Same |
| 08/28/2008 | US20080206133 Patient-specific anticancer monoclonal antibodies for staging and diagnosis of a cancer, treating tumors and metastases; monoclonal antibody produced by hybridoma; conjugates with cytotoxic agents for tissue-targeted therapy |
| 08/28/2008 | US20080206132 Cancerous Disease Modifying Antibodies |
| 08/28/2008 | CA2678963A1 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 08/28/2008 | CA2678863A1 Engineered anti-il-23p19 antibodies |
| 08/28/2008 | CA2678749A1 Engineered anti-il-23p19 antibodies |
| 08/28/2008 | CA2678493A1 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease |
| 08/28/2008 | CA2678304A1 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 08/28/2008 | CA2678218A1 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization |
| 08/28/2008 | CA2677878A1 Monoclonal anti-cxcl13 antibodies |
| 08/27/2008 | EP1962094A1 Detecting agent and therapeutic agent for highly malignant breast cancer |
| 08/27/2008 | EP1961819A2 Composition and methods for the therapy and diagnosis of lung cancer |
| 08/27/2008 | EP1961818A2 Novel fetal genes |
| 08/27/2008 | EP1961813A2 Human cyclin-dependent kinase (hPNQALRE) |
| 08/27/2008 | EP1961811A1 Novel cytokine ZCYTOR17 ligand |
| 08/27/2008 | EP1961768A1 Recombinant IL-18 Antibodies useful in Treatment of IL-18 mediated Disorders |